ELION THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 24 Mar 2026)
What this means for you
Not registered yet, but its 14 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98314270
- Mark type
- Stylized text
- Filed
- 14 Dec 2023
- Published for opposition
- 25 Feb 2025
- Attorney of record
- J. Dickson Phillips III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infective medications; Anti-fungal medications for administration by a healthcare professional in a healthcare setting to treat systemic fungal infections or invasive fungal disease
Owner
- ELION THERAPEUTICS, INC., NEW YORK, NY, US
- ELION THERAPEUTICS, INC., NEW YORK, NY, US
- Sfunga Therapeutics, Inc., New York, NY, US
Prosecution history
- 25 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2026 — SOU EXTENSION 2 GRANTED
- 24 Mar 2026 — SOU EXTENSION 2 FILED
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2025 — SOU EXTENSION 1 GRANTED
- 24 Sept 2025 — SOU EXTENSION 1 FILED
- 24 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2025 — PUBLISHED FOR OPPOSITION
- 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE